The role of CHD7 and the newly identified WDR11 gene in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome

Molecular and Cellular Endocrinology

Volumn 346, Issue 1-2, 2011, Pages 74-83

  Kim, Hyung Goo ^a   Layman, Lawrence C ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Anosmia; CHARGE syndrome; CHD7 gene; GnRH neuron; Idiopathic hypogonadotropic hypogonadism; Kallmann syndrome

Indexed keywords

CHROMODOMAIN HELICASE DNA BINDING PROTEIN 7; DNA BINDING PROTEIN; UNCLASSIFIED DRUG;

CHD7 GENE; CHROMATIN ASSEMBLY AND DISASSEMBLY; DISEASE ASSOCIATION; GENE; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; IDIOPATHIC SCOLIOSIS; KALLMANN SYNDROME; MOLECULAR GENETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYNDROME CHARGE; WDR11 GENE;

ANIMALS; CHARGE SYNDROME; DNA HELICASES; DNA-BINDING PROTEINS; HUMANS; HYPOGONADISM; KALLMANN SYNDROME; MEMBRANE PROTEINS; PROTO-ONCOGENE PROTEINS;

EID: 80053385843     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.07.013     Document Type: Review

References (56)

1. Batsukh T., Pieper L., Koszucka A.M., von Velsen N., Hoyer-Fender S., Elbracht M., Bergman J.E., Hoefsloot L.H., Pauli S. CHD8 interacts with CHD7, a protein which is mutated in CHARGE syndrome. Hum. Mol. Genet. 2010, 19:2858-2866.
2. Bergman J.E., Bocca G., Hoefsloot L.H., Meiners L.C., van Ravenswaaij-Arts C.M. Anosmia Predicts Hypogonadotropic Hypogonadism in CHARGE Syndrome. J. Pediatr 2010.
3. Bergman J.E., Bosman E.A., van Ravenswaaij-Arts C.M., Steel K.P. Study of smell and reproductive organs in a mouse model for CHARGE syndrome. Eur. J. Hum. Genet. 2010, 18:171-177.
4. Bhagavath B., Podolsky R.H., Ozata M., Bolu E., Bick D.P., Kulharya A., Sherins R.J., Layman L.C. Clinical and molecular characterization of a large sample of patients with hypogonadotropic hypogonadism. Fertil. Steril. 2006, 85:706-713.
5. Blake K.D., Davenport S.L., Hall B.D., Hefner M.A., Pagon R.A., Williams M.S., Lin A.E., Graham J.M. CHARGE association: an update and review for the primary pediatrician. Clin. Pediatr. (Phila) 1998, 37:159-173.
6. Blake K.D., Prasad C. CHARGE syndrome. Orphanet. J. Rare Dis. 2006, 1:34.
7. Blake K.D., Russell-Eggitt I.M., Morgan D.W., Ratcliffe J.M., Wyse R.K. Who's in CHARGE? Multidisciplinary management of patients with CHARGE association. Arch. Dis. Child. 1990, 65:217-223.
8. Bosman E.A., Penn A.C., Ambrose J.C., Kettleborough R., Stemple D.L., Steel K.P. Multiple mutations in mouse Chd7 provide models for CHARGE syndrome. Hum. Mol. Genet. 2005, 14:3463-3476.
9. Bouazoune K., Mitterweger A., Langst G., Imhof A., Akhtar A., Becker P.B., Brehm A. The dMi-2 chromodomains are DNA binding modules important for ATP-dependent nucleosome mobilization. Embo J. 2002, 21:2430-2440.
10. Bouligand J., Ghervan C., Tello J.A., Brailly-Tabard S., Salenave S., Chanson P., Lombes M., Millar R.P., Guiochon-Mantel A., Young J. Isolated familial hypogonadotropic hypogonadism and a GNRH1 mutation. N. Engl. J. Med. 2009, 360:2742-2748.
11. Chalouhi C., Faulcon P., Le Bihan C., Hertz-Pannier L., Bonfils P., Abadie V. Olfactory evaluation in children: application to the CHARGE syndrome. Pediatrics 2005, 116:e81-e88.
12. Chan Y.M., de Guillebon A., Lang-Muritano M., Plummer L., Cerrato F., Tsiaras S., Gaspert A., Lavoie H.B., Wu C.H., Crowley W.F., Amory J.K., Pitteloud N., Seminara S.B. GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism. Proc. Natl. Acad. Sci. USA 2009.
13. Crowley W.F., Filicori M., Spratt D.I., Santoro N.F. The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Recent Prog. Horm. Res. 1985, 41:473-531.
14. Dauber A., Hirschhorn J.N., Picker J., Maher T.A., Milunsky A. Delayed puberty due to a novel mutation in CHD7 causing CHARGE syndrome. Pediatrics 2010, 126:e1594-e1598.
15. de Roux N., Young J., Misrahi M., Genet R., Chanson P., Schaison G., Milgrom E. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N. Engl. J. Med. 1997, 337:1597-1602.
16. Delahaye A., Sznajer Y., Lyonnet S., Elmaleh-Berges M., Delpierre I., Audollent S., Wiener-Vacher S., Mansbach A.L., Amiel J., Baumann C., Bremond-Gignac D., Attie-Bitach T., Verloes A., Sanlaville D. Familial CHARGE syndrome because of CHD7 mutation: clinical intra- and interfamilial variability. Clin. Genet. 2007, 72:112-121.
17. Foppiani L., Maffe A., Forzano F. CHARGE syndrome as unusual cause of hypogonadism: endocrine and molecular evaluation. Andrologia 2010, 42:326-330.
18. Franco B., Guioli S., Pragliola A., Incerti B., Bardoni B., Tonlorenzi R., Carrozzo R., Maestrini E., Pieretti M., Taillon-Miller P., Brown C.J., Willard H.F., Lawrence C., Persico M., Camerino G., Ballabio A. A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 1991, 353:529-536.
19. Gao X., Gordon D., Zhang D., Browne R., Helms C., Gillum J., Weber S., Devroy S., Swaney S., Dobbs M., Morcuende J., Sheffield V., Lovett M., Bowcock A., Herring J., Wise C. CHD7 gene polymorphisms are associated with susceptibility to idiopathic scoliosis. Am. J. Hum. Genet. 2007, 80:957-965.
20. Habiby R.L., Boepple P., Nachtigall L., Sluss P.M., Crowley W.F., Jameson J.L. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalmic and pituitary defects in gonadotropin production. J. Clin. Invest. 1996, 98:1055-1062.
21. Hall B.D. Choanal atresia and associated multiple anomalies. J. Pediatr. 1979, 95:395-398.
22. Hittner H.M., Hirsch N.J., Kreh G.M., Rudolph A.J. Colobomatous microphthalmia, heart disease, hearing loss, and mental retardation - a syndrome. J. Pediatr. Ophthalmol. Strabismus 1979, 16:122-128.
23. Hurd E.A., Capers P.L., Blauwkamp M.N., Adams M.E., Raphael Y., Poucher H.K., Martin D.M. Loss of Chd7 function in gene-trapped reporter mice is embryonic lethal and associated with severe defects in multiple developing tissues. Mamm. Genome 2007, 18:94-104.
24. Hurst J.A., Meinecke P., Baraitser M. Balanced t(6;8)(6p8p;6q8q) and the CHARGE association. J. Med. Genet. 1991, 28:54-55.
25. Jongmans M.C., Admiraal R.J., van der Donk K.P., Vissers L.E., Baas A.F., Kapusta L., van Hagen J.M., Donnai D., de Ravel T.J., Veltman J.A., Geurts van Kessel A., De Vries B.B., Brunner H.G., Hoefsloot L.H., van Ravenswaaij C.M. CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene. J. Med. Genet. 2006, 43:306-314.
26. Jongmans M.C., Hoefsloot L.H., van der Donk K.P., Admiraal R.J., Magee A., van de Laar I., Hendriks Y., Verheij J.B., Walpole I., Brunner H.G., van Ravenswaaij C.M. Familial CHARGE syndrome and the CHD7 gene: a recurrent missense mutation, intrafamilial recurrence and variability. Am. J. Med. Genet. A 2008, 146A:43-50.
27. Jongmans M.C., van Ravenswaaij-Arts C.M., Pitteloud N., Ogata T., Sato N., Claahsen-van der Grinten H.L., van der Donk K., Seminara S., Bergman J.E., Brunner H.G., Crowley W.F., Hoefsloot L.H. CHD7 mutations in patients initially diagnosed with Kallmann syndrome-the clinical overlap with CHARGE syndrome. Clin. Genet. 2009, 75:65-71.
28. Kim H.G., Ahn J.W., Kurth I., Ullmann R., Kim H.T., Kulharya A., Ha K.S., Itokawa Y., Meliciani I., Wenzel W., Lee D., Rosenberger G., Ozata M., Bick D.P., Sherins R.J., Nagase T., Tekin M., Kim S.H., Kim C.H., Ropers H.H., Gusella J.F., Kalscheuer V., Choi C.Y., Layman L.C. WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am. J. Hum. Genet. 2010, 87:465-479.
29. Kim H.G., Kurth I., Lan F., Meliciani I., Wenzel W., Eom S.H., Kang G.B., Rosenberger G., Tekin M., Ozata M., Bick D.P., Sherins R.J., Walker S.L., Shi Y., Gusella J.F., Layman L.C. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am. J. Hum. Genet. 2008, 83:511-519.
30. Lalani S.R., Safiullah A.M., Fernbach S.D., Harutyunyan K.G., Thaller C., Peterson L.E., McPherson J.D., Gibbs R.A., White L.D., Hefner M., Davenport S.L., Graham J.M., Bacino C.A., Glass N.L., Towbin J.A., Craigen W.J., Neish S.R., Lin A.E., Belmont J.W. Spectrum of CHD7 Mutations in 110 Individuals with CHARGE Syndrome and Genotype-Phenotype Correlation. Am. J. Hum. Genet. 2006, 78:303-314.
31. Layman L.C. Genetic diagnosis of hypogonadotropic hypogonadism and Kallmann syndrome. Genetic Diagnosis of Endocrine Disorders 2010, 217-225. Academic Press, Amsterdam. R.E. Weiss, S. Refetoff (Eds.).
32. Layman L.C., Cohen D.P., Jin M., Xie J., Li Z., Reindollar R.H., Bolbolan S., Bick D.P., Sherins R.R., Duck L.W., Musgrove L.C., Sellers J.C., Neill J.D. Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. Nat. Genet. 1998, 18:14-15.
33. Layman L.C., Lee E.J., Peak D.B., Namnoum A.B., Vu K.V., van Lingen B.L., Gray M.R., McDonough P.G., Reindollar R.H., Jameson J.L. Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone beta-subunit gene. N. Engl. J. Med. 1997, 337:607-611.
34. Layman W.S., McEwen D.P., Beyer L.A., Lalani S.R., Fernbach S.D., Oh E., Swaroop A., Hegg C.C., Raphael Y., Martens J.R., Martin D.M. Defects in neural stem cell proliferation and olfaction in Chd7 deficient mice indicate a mechanism for hyposmia in human CHARGE syndrome. Hum. Mol. Genet. 2009, 18:1909-1923.
35. Legouis R., Hardelin J.P., Levilliers J., Claverie J.M., Compain S., Wunderle V., Millasseau P., Le Paslier D., Cohen D., Caterina D., Bougueleret L., Delemarre-Van de Waal H., Lutfalla G., Weissenbach J., Petit C. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 1991, 67:423-435.
36. Lofrano-Porto A., Barra G.B., Giacomini L.A., Nascimento P.P., Latronico A.C., Casulari L.A., da Rocha Neves Fde A. Luteinizing hormone beta mutation and hypogonadism in men and women. N. Engl. J. Med. 2007, 357:897-904.
37. Marfella C.G., Imbalzano A.N. The Chd family of chromatin remodelers. Mutat. Res. 2007, 618:30-40.
38. Mason A.J., Hayflick J.S., Zoeller T., Young W.S., Phillips H.S., Nikolics K., Seeburg P.H. A deletion truncating the gonadotropin-releasing hormone gene is responsible for hypogonadism in the hpg mouse. Science 1986, 234:1366-1371.
39. Matthews C.H., Borgato S., Beck-Peccoz P., Adams M., Tone Y., Gambin G., Casagrande S., Tedeschini G., Benedetti A., Chatterjee V.K.K. Primary amenorrhea and infertility due to a mutation in the β-subunit of follicle-stimulating hormone. Nat. Genet. 1993, 5:83-86.
40. Ogata T., Fujiwara I., Ogawa E., Sato N., Udaka T., Kosaki K. Kallmann syndrome phenotype in a female patient with CHARGE syndrome and CHD7 mutation. Endocr. J. 2006, 53:741-743.
41. Pagon R.A., Graham J.M., Zonana J., Yong S.L. Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE association. J. Pediatr. 1981, 99:223-227.
42. Pinto G., Abadie V., Mesnage R., Blustajn J., Cabrol S., Amiel J., Hertz-Pannier L., Bertrand A.M., Lyonnet S., Rappaport R., Netchine I. CHARGE syndrome includes hypogonadotropic hypogonadism and abnormal olfactory bulb development. J. Clin. Endocrinol. Metab. 2005, 90:5621-5626.
43. Pitteloud N., Acierno J.S., Meysing A., Eliseenkova A.V., Ma J., Ibrahimi O.A., Metzger D.L., Hayes F.J., Dwyer A.A., Hughes V.A., Yialamas M., Hall J.E., Grant E., Mohammadi M., Crowley W.F. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc. Natl. Acad. Sci. USA 2006, 103:6281-6286.
44. Pitteloud N., Quinton R., Pearce S., Raivio T., Acierno J., Dwyer A., Plummer L., Hughes V., Seminara S., Cheng Y.Z., Li W.P., Maccoll G., Eliseenkova A.V., Olsen S.K., Ibrahimi O.A., Hayes F.J., Boepple P., Hall J.E., Bouloux P., Mohammadi M., Crowley W. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J. Clin. Invest. 2007, 117:457-463.
45. Sanlaville D., Etchevers H.C., Gonzales M., Martinovic J., Clement-Ziza M., Delezoide A.L., Aubry M.C., Pelet A., Chemouny S., Cruaud C., Audollent S., Esculpavit C., Goudefroye G., Ozilou C., Fredouille C., Joye N., Morichon-Delvallez N., Dumez Y., Weissenbach J., Munnich A., Amiel J., Encha-Razavi F., Lyonnet S., Vekemans M., Attie-Bitach T. Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development. J. Med. Genet. 2006, 43:211-217.
46. Sanlaville D., Verloes A. CHARGE syndrome: an update. Eur. J. Hum. Genet. 2007, 15:389-399.
47. Schnetz M.P., Bartels C.F., Shastri K., Balasubramanian D., Zentner G.E., Balaji R., Zhang X., Song L., Wang Z., Laframboise T., Crawford G.E., Scacheri P.C. Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns. Genome Res. 2009, 19:590-601.
48. Schnetz M.P., Handoko L., Akhtar-Zaidi B., Bartels C.F., Pereira C.F., Fisher A.G., Adams D.J., Flicek P., Crawford G.E., Laframboise T., Tesar P., Wei C.L., Scacheri P.C. CHD7 targets active gene enhancer elements to modulate ES cell-specific gene expression. PLoS Genet. 2010, 6:e1001023.
49. Sykiotis G.P., Plummer L., Hughes V.A., Au M., Durrani S., Nayak-Young S., Dwyer A.A., Quinton R., Hall J.E., Gusella J.F., Seminara S.B., Crowley W.F., Pitteloud N. Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. Proc. Natl. Acad. Sci. USA 2010, 107:15140-15144.
50. Verloes A. Updated diagnostic criteria for CHARGE syndrome: a proposal. Am. J. Med. Genet. A 2005, 133A:306-308.
51. Vissers L.E., van Ravenswaaij C.M., Admiraal R., Hurst J.A., de Vries B.B., Janssen I.M., van der Vliet W.A., Huys E.H., de Jong P.J., Hamel B.C., Schoenmakers E.F., Brunner H.G., Veltman J.A., van Kessel A.G. Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nat. Genet. 2004, 36:955-957.
52. Vuorela P., Ala-Mello S., Saloranta C., Penttinen M., Poyhonen M., Huoponen K., Borozdin W., Bausch B., Botzenhart E.M., Wilhelm C., Kaariainen H., Kohlhase J. Molecular analysis of the CHD7 gene in CHARGE syndrome: identification of 22 novel mutations and evidence for a low contribution of large CHD7 deletions. Genet. Med. 2007, 9:690-694.
53. Weiss J., Axelrod L., Whitcomb R.W., Harris P.E., Crowley W.F., Jameson J.L. Hypogonadism caused by a single amino acid substituion in the β subunit of luteinizing hormone. N. Engl. J. Med. 1992, 326:179-183.
54. Wheeler P.G., Quigley C.A., Sadeghi-Nejad A., Weaver D.D. Hypogonadism and CHARGE association. Am. J. Med. Genet. 2000, 94:228-231.
55. Wierman M.E., Pawlowski J.E., Allen M.P., Xu M., Linseman D.A., Nielsen-Preiss S. Molecular mechanisms of gonadotropin-releasing hormone neuronal migration. Trends Endocrinol. Metab. 2004, 15:96-102.
56. Zentner G.E., Layman W.S., Martin D.M., Scacheri P.C. Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. Am. J. Med. Genet. A 2010, 152A:674-686.